, Réduire les risques de séquelles et de second cancer -Les 17 objectifs du Plan | Institut National Du Cancer, vol.8, 2014.

C. L. Rock, C. Doyle, W. Demark-wahnefried, J. Meyerhardt, K. S. Courneya et al., Nutrition and physical activity guidelines for cancer survivors, CA Cancer J Clin, vol.62, pp.243-274, 2012.

C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-wahnefried et al., Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices, CA Cancer J Clin, vol.56, pp.323-353, 2006.

E. Thivat, S. Thérondel, O. Lapirot, C. Abrial, P. Gimbergues et al., Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse, BMC Cancer, vol.10, p.648, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00663871

É. Gadéa, É. Thivat, Q. Wang-lopez, M. Viala, R. Paulon et al., Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms

, Bull Cancer (Paris), vol.100, pp.865-870, 2013.

S. I. Mishra, R. W. Scherer, P. M. Geigle, D. R. Berlanstein, O. Topaloglu et al., Exercise interventions on health-related quality of life for cancer survivors, Cochrane Database Syst Rev, vol.007566, 2012.

X. Zhang, Y. Li, and D. Liu, Effects of exercise on the quality of life in breast cancer patients: a systematic review of randomized controlled trials, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, 2018.

E. M. Ibrahim and A. Al-homaidh, Physical activity and survival after breast cancer diagnosis: meta-analysis of published studies, Med Oncol, vol.28, pp.753-765, 2010.

M. D. Holmes, W. Y. Chen, D. Feskanich, C. H. Kroenke, and G. A. Colditz, Physical activity and survival after breast cancer diagnosis, JAMA, vol.293, pp.2479-2486, 2005.

C. M. Blanchard, K. S. Courneya, and K. Stein, American Cancer Society's SCS-II: Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II, J Clin Oncol Off J Am Soc Clin Oncol, vol.26, pp.2198-2204, 2008.

E. J. Coups and J. S. Ostroff, A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls, Prev Med, vol.40, pp.702-711, 2005.

E. G. Eakin, D. R. Youlden, P. D. Baade, S. P. Lawler, M. M. Reeves et al., Health behaviors of cancer survivors: data from an Australian population-based survey, Cancer Causes Control CCC, vol.18, pp.881-894, 2007.

H. Arem, S. C. Moore, A. Patel, P. Hartge, A. Berrington-de-gonzalez et al., Leisure time physical activity and mortality: a detailed pooled analysis of the dose-response relationship, JAMA Intern Med, vol.175, pp.959-967, 2015.

H. H. Kyu, V. F. Bachman, L. T. Alexander, J. E. Mumford, A. Afshin et al., Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study, BMJ, vol.354, p.3857, 2013.

A. F. Yu and L. W. Jones, Breast cancer treatment-associated cardiovascular toxicity and effects of exercise countermeasures, Cardio-Oncol Lond Engl, vol.2, 2016.

S. M. Swain, F. S. Whaley, and M. S. Ewer, Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials, Cancer, vol.97, pp.2869-2879, 2003.

L. A. Smith, V. R. Cornelius, C. J. Plummer, G. Levitt, M. Verrill et al., Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials, BMC Cancer, vol.10, p.337, 2010.

S. Mantarro, M. Rossi, M. Bonifazi, D. 'amico, R. Blandizzi et al., Risk of severe cardiotoxicity following treatment with trastuzumab: a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer, Intern Emerg Med, vol.11, pp.123-140, 2016.

T. Chen, T. Xu, Y. Li, C. Liang, J. Chen et al., Risk of cardiac dysfunction with trastuzumab in breast cancer patients: a meta-analysis, Cancer Treat Rev, vol.37, pp.312-320, 2011.

I. Smith, M. Procter, R. D. Gelber, S. Guillaume, A. Feyereislova et al., 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial, Lancet Lond Engl, vol.369, pp.29-36, 2007.

Z. Luis, L. Patrizio, R. Daniel, A. Victor, A. Riccardo et al., ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines, Eur J Heart Fail, vol.19, pp.9-42, 2016.

M. Procter, T. M. Suter, E. De-azambuja, U. Dafni, V. Van-dooren et al., Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial, J Clin Oncol Off J Am Soc Clin Oncol, vol.28, pp.3422-3428, 2010.

M. J. Piccart-gebhart, M. Procter, B. Leyland-jones, A. Goldhirsch, M. Untch et al., Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer, N Engl J Med, vol.353, pp.1659-1672, 2005.

H. L. Mcarthur and S. Chia, Cardiotoxicity of trastuzumab in clinical practice, N Engl J Med, vol.357, pp.94-95, 2007.

B. Chen, X. Peng, L. Pentassuglia, C. C. Lim, and D. B. Sawyer, Molecular and cellular mechanisms of anthracycline cardiotoxicity, Cardiovasc Toxicol, vol.7, pp.114-121, 2007.

T. Sim?nek, M. Stérba, O. Popelová, M. Adamcová, R. Hrdina et al., Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron, Pharmacol Rep PR, vol.61, pp.154-171, 2009.

K. B. Wallace, Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis, Cardiovasc Toxicol, vol.7, pp.101-107, 2007.

W. Zhu, M. H. Soonpaa, H. Chen, W. Shen, R. M. Payne et al., Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway, Circulation, vol.119, pp.99-106, 2009.

D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich et al., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science, vol.235, pp.177-182, 1987.

M. A. Cobleigh, C. L. Vogel, D. Tripathy, N. J. Robert, S. Scholl et al., Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J Clin Oncol Off J Am Soc Clin Oncol, vol.17, pp.2639-2648, 1999.

J. Baselga, X. Carbonell, N. Castañeda-soto, M. Clemens, M. Green et al., Phase II study of efficacy, safety, and pharmacokinetics of trastuzumab monotherapy administered on a 3-weekly schedule, J Clin Oncol Off J Am Soc Clin Oncol, vol.23, pp.2162-2171, 2005.

D. J. Slamon, B. Leyland-jones, S. Shak, H. Fuchs, V. Paton et al., Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2, N Engl J Med, vol.344, pp.783-792, 2001.

M. Marty, F. Cognetti, D. Maraninchi, R. Snyder, L. Mauriac et al., Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group, J Clin Oncol Off J Am Soc Clin Oncol, vol.23, pp.4265-4274, 2005.

M. Cuello, S. A. Ettenberg, A. S. Clark, M. M. Keane, R. H. Posner et al., Down-regulation of the erbB-2 receptor by trastuzumab (herceptin) enhances tumor necrosis factor-related apoptosis-inducing ligandmediated apoptosis in breast and ovarian cancer cell lines that overexpress erbB-2, Cancer Res, vol.61, pp.4892-4900, 2001.

E. H. Romond, E. A. Perez, J. Bryant, V. J. Suman, C. E. Geyer et al., Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer, N Engl J Med, vol.353, pp.1673-1684, 2005.

P. P. Sengupta, D. W. Northfelt, F. Gentile, J. L. Zamorano, and B. K. Khandheria, Trastuzumab-induced cardiotoxicity: heart failure at the crossroads, Mayo Clin Proc, vol.83, pp.197-203, 2008.

A. Farolfi, E. Melegari, M. Aquilina, E. Scarpi, T. Ibrahim et al., Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factors, Heart Br Card Soc, vol.99, pp.634-639, 2013.

G. Fried, T. Regev, and M. Moskovitz, Trastuzumab-related cardiac events in the treatment of early breast cancer, Breast Cancer Res Treat, vol.142, pp.1-7, 2013.

P. Thavendiranathan, H. Abdel-qadir, H. D. Fischer, X. Camacho, E. Amir et al., Breast Cancer Therapy-Related Cardiac Dysfunction in Adult Women Treated in Routine Clinical Practice: A PopulationBased Cohort Study, J Clin Oncol Off J Am Soc Clin Oncol, vol.34, pp.2239-2246, 2016.

L. Moja, L. Tagliabue, S. Balduzzi, E. Parmelli, V. Pistotti et al., Trastuzumab containing regimens for early breast cancer, vol.006243, 2012.

A. Albini, E. Cesana, F. Donatelli, R. Cammarota, E. O. Bucci et al., Cardio-oncology in targeting the HER receptor family: the puzzle of different cardiotoxicities of HER2 inhibitors, Future Cardiol, vol.7, pp.693-704, 2011.

N. L. Spector, Y. Yarden, B. Smith, L. Lyass, P. Trusk et al., Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells, Proc Natl Acad Sci U S A, vol.104, pp.10607-10612, 2007.

S. J. Fuller, K. Sivarajah, and P. H. Sugden, ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium, J Mol Cell Cardiol, vol.44, pp.831-854, 2008.

Y. Y. Zhao, D. R. Sawyer, R. R. Baliga, D. J. Opel, X. Han et al., Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes, J Biol Chem, vol.273, pp.10261-10269, 1998.

R. Iwamoto, S. Yamazaki, M. Asakura, S. Takashima, H. Hasuwa et al., Heparin-binding EGF-like growth factor and ErbB signaling is essential for heart function, Proc Natl Acad Sci U S A, vol.100, pp.3221-3226, 2003.

G. W. De-keulenaer, K. Doggen, and K. Lemmens, The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy, Circ Res, vol.106, pp.35-46, 2010.

G. M. Cote, D. B. Sawyer, and B. A. Chabner, ERBB2 inhibition and heart failure, N Engl J Med, vol.368, p.876, 2013.

A. Seidman, C. Hudis, M. K. Pierri, S. Shak, V. Paton et al., Cardiac dysfunction in the trastuzumab clinical trials experience, J Clin Oncol Off J Am Soc Clin Oncol, vol.20, pp.1215-1221, 2002.

I. J. Dahabreh, H. Linardou, F. Siannis, G. Fountzilas, and S. Murray, Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials, The Oncologist, vol.13, pp.620-630, 2008.

E. Bowles, R. Wellman, H. S. Feigelson, A. A. Onitilo, A. N. Freedman et al., Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study, J Natl Cancer Inst, vol.104, pp.1293-1305, 2012.

A. Schneeweiss, S. Chia, T. Hickish, V. Harvey, A. Eniu et al., Pertuzumab plus trastuzumab in combination with standard neoadjuvant anthracycline-containing and anthracycline-free chemotherapy regimens in patients with HER2-positive early breast cancer: a randomized phase II cardiac safety study (TRYPHAENA), Ann Oncol Off J Eur Soc Med Oncol, vol.24, pp.2278-2284, 2013.

M. Sendur, S. Aksoy, and K. Altundag, Cardiotoxicity of novel HER2-targeted therapies, Curr Med Res Opin, vol.29, pp.1015-1024, 2013.

C. M. Schneider, C. C. Hsieh, L. K. Sprod, S. D. Carter, and R. Hayward, Effects of supervised exercise training on cardiopulmonary function and fatigue in breast cancer survivors during and after treatment, Cancer, vol.110, pp.918-925, 2007.

A. S. Fairey, K. S. Courneya, C. J. Field, G. J. Bell, L. W. Jones et al., Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial, Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, vol.12, pp.721-727, 2003.

T. Cornette, F. Vincent, S. Mandigout, M. T. Antonini, S. Leobon et al., Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial, Eur J Phys Rehabil Med, vol.52, pp.223-232, 2016.

V. De-luca, C. Minganti, P. Borrione, E. Grazioli, C. Cerulli et al., Effects of concurrent aerobic and strength training on breast cancer survivors: a pilot study, Public Health, vol.136, pp.126-132, 2016.

W. E. Hornsby, P. S. Douglas, M. J. West, A. A. Kenjale, A. R. Lane et al., Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial, Acta Oncol Stockh Swed, vol.53, pp.65-74, 2014.

C. M. Dieli-conwright, K. S. Courneya, W. Demark-wahnefried, N. Sami, K. Lee et al., Aerobic and resistance exercise improves physical fitness, bone health, and quality of life in overweight and obese breast cancer survivors: a randomized controlled trial, Breast Cancer Res BCR, vol.20, p.124, 2018.

A. Foucaut, S. E. Berthouze-aranda, M. Touillaud, A. Kempf-lépine, C. Baudinet et al., Reduction of health risk factors through an adapted physical activity program in patients with breast cancer, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.22, pp.1097-1104, 2014.
URL : https://hal.archives-ouvertes.fr/hal-02128318

C. Kim, D. Kang, B. A. Smith, and K. A. Landers, Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy, Cancer Nurs, vol.29, pp.156-165, 2006.

G. G. Kolden, T. J. Strauman, A. Ward, J. Kuta, T. E. Woods et al., A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits, Psychooncology, vol.11, pp.447-456, 2002.

H. J. Leach, J. M. Danyluk, and K. C. Nishimura, Culos-Reed SN: Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.24, pp.4597-4606, 2016.

M. Noble, C. Russell, L. Kraemer, and M. Sharratt, UW WELL-FIT: the impact of supervised exercise programs on physical capacity and quality of life in individuals receiving treatment for cancer, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.20, pp.865-873, 2012.

K. M. Sturgeon, B. Ky, J. R. Libonati, and K. H. Schmitz, The effects of exercise on cardiovascular outcomes before, during, and after treatment for breast cancer, Breast Cancer Res Treat, vol.143, pp.219-226, 2014.

L. W. Jones, M. J. Haykowsky, J. J. Swartz, P. S. Douglas, and J. R. Mackey, Early Breast Cancer Therapy and Cardiovascular Injury, J Am Coll Cardiol, vol.50, pp.1435-1441, 2007.

A. N. Kavazis, J. M. Mcclung, D. A. Hood, and S. K. Powers, Exercise induces a cardiac mitochondrial phenotype that resists apoptotic stimuli, Am J Physiol Heart Circ Physiol, vol.294, pp.928-935, 2008.

A. Ascensão, R. Ferreira, and J. Magalhães, Exercise-induced cardioprotection--biochemical, morphological and functional evidence in whole tissue and isolated mitochondria, Int J Cardiol, vol.117, pp.16-30, 2007.

L. W. Jones, L. A. Habel, E. Weltzien, A. Castillo, D. Gupta et al., Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer, J Clin Oncol Off J Am Soc Clin Oncol, vol.34, pp.2743-2749, 2016.

M. J. Haykowsky, J. R. Mackey, R. B. Thompson, L. W. Jones, and D. I. Paterson, Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training, Clin Cancer Res, vol.15, pp.4963-4967, 2009.

K. S. Courneya, R. J. Segal, J. R. Mackey, K. Gelmon, R. D. Reid et al., Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial, J Clin Oncol Off J Am Soc Clin Oncol, vol.25, pp.4396-4404, 2007.

N. Travier, M. J. Velthuis, S. Bisschop, C. N. Van-den-buijs, B. Monninkhof et al., Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial, BMC Med, vol.13, p.121, 2015.

K. S. Courneya, D. C. Mckenzie, J. R. Mackey, K. Gelmon, C. M. Friedenreich et al., Subgroup effects in a randomised trial of different types and doses of exercise during breast cancer chemotherapy, Br J Cancer, vol.111, pp.1718-1725, 2014.

Q. Jacquinot, N. Meneveau, M. Chatot, F. Bonnetain, B. Degano et al., A phase 2 randomized trial to evaluate the impact of a supervised exercise program on cardiotoxicity at 3 months in patients with HER2 overexpressing breast cancer undergoing adjuvant treatment by trastuzumab: design of the CARDAPAC study, BMC Cancer, vol.17, p.425, 2017.

A. Ginzac, T. Émilie, M. Pascale, D. Isabelle, V. P. Judith et al., Weight evolution during endocrine therapy for breast cancer in postmenopausal patients: impact of initial fat mass percentage and previous adjuvant treatments, Clin Breast Cancer

S. Battisti, F. M. Guida, F. Coppa, D. M. Vaccaro, D. Santini et al., Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry, Clin Breast Cancer, vol.14, pp.365-370, 2014.

J. Zhu, L. Ebert, X. Liu, and S. Chan, A mobile application of breast cancer e-support program versus routine Care in the treatment of Chinese women with breast cancer undergoing chemotherapy: study protocol for a randomized controlled trial, BMC Cancer, vol.17, p.291, 2017.

S. S. Coughlin, G. M. Besenyi, D. Bowen, D. Leo, and G. , Development of the Physical activity and Your Nutrition for Cancer (PYNC) smartphone app for preventing breast cancer in women, vol.3, p.5, 2017.

I. Y. Cheong, A. Sy, W. C. Cha, M. Y. Rha, S. T. Kim et al., Efficacy of Mobile Health Care Application and Wearable Device in Improvement of Physical Performance in Colorectal Cancer Patients Undergoing Chemotherapy, Clin Colorectal Cancer, vol.17, pp.353-362, 2018.

K. S. Courneya, D. C. Mckenzie, R. D. Reid, J. R. Mackey, K. Gelmon et al., Barriers to supervised exercise training in a randomized controlled trial of breast cancer patients receiving chemotherapy, Ann Behav Med Publ Soc Behav Med, vol.35, pp.116-122, 2008.

A. Henriksson, C. Arving, B. Johansson, H. Igelström, and K. Nordin, Perceived barriers to and facilitators of being physically active during adjuvant cancer treatment, Patient Educ Couns, vol.99, pp.1220-1226, 2016.

A. Husebø, B. Karlsen, H. Allan, J. A. Søreide, and E. Bru, Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise programme during adjuvant chemotherapy: a focus group study, J Clin Nurs, vol.24, pp.500-510, 2015.

C. Emslie, F. Whyte, A. Campbell, N. Mutrie, L. Lee et al., I wouldn't have been interested in just sitting round a table talking about cancer"; exploring the experiences of women with breast cancer in a group exercise trial, Health Educ Res, vol.22, pp.827-838, 2007.

A. Wurz, A. St-aubin, and J. Brunet, Breast cancer survivors' barriers and motives for participating in a groupbased physical activity program offered in the community, Support Care Cancer Off J Multinatl Assoc Support Care Cancer, vol.23, pp.2407-2416, 2015.

K. Hefferon, H. Murphy, J. Mcleod, N. Mutrie, and A. Campbell, Understanding barriers to exercise implementation 5-year post-breast cancer diagnosis: a large-scale qualitative study, Health Educ Res, vol.28, pp.843-856, 2013.

S. Y. Loh, S. Y. Lee, K. F. Quek, and L. Murray, Barriers to participation in a randomized controlled trial of Qigong exercises amongst cancer survivors: lessons learnt, Asian Pac J Cancer Prev APJCP, vol.13, pp.6337-6342, 2012.

C. Charlier, E. Van-hoof, E. Pauwels, L. Lechner, and H. Spittaels, De Bourdeaudhuij I: The contribution of general and cancer-related variables in explaining physical activity in a breast cancer population 3 weeks to 6 months post-treatment, Psychooncology, vol.22, pp.203-211, 2013.

S. Y. Loh, S. Chew, and S. Lee, Barriers to exercise: perspectives from multiethnic cancer survivors in Malaysia, Asian Pac J Cancer Prev APJCP, vol.12, pp.1483-1488, 2011.

A. J. Ottenbacher, R. S. Day, W. C. Taylor, S. V. Sharma, R. Sloane et al., Exercise among breast and prostate cancer survivors--what are their barriers?, J Cancer Surviv Res Pract, vol.5, pp.413-419, 2011.

L. Steinhilper, S. Geyer, and S. Sperlich, Health behavior change among breast cancer patients, Int J Public Health, vol.58, pp.603-613, 2013.

L. Q. Rogers, C. Matevey, P. Hopkins-price, P. Shah, G. Dunnington et al., Exploring social cognitive theory constructs for promoting exercise among breast cancer patients, Cancer Nurs, vol.27, pp.462-473, 2004.

M. Browall, S. Mijwel, H. Rundqvist, and Y. Wengström, Physical Activity During and After Adjuvant Treatment for Breast Cancer: An Integrative Review of Women's Experiences, Integr Cancer Ther, vol.17, pp.16-30, 2018.

F. M. Perna, L. Craft, C. S. Carver, and M. H. Antoni, Negative affect and barriers to exercise among early stage breast cancer patients, Health Psychol Off J Div Health Psychol Am Psychol Assoc, vol.27, pp.275-279, 2008.

L. W. Jones, K. S. Courneya, A. S. Fairey, and J. R. Mackey, Effects of an oncologist's recommendation to exercise on self-reported exercise behavior in newly diagnosed breast cancer survivors: a single-blind, randomized controlled trial, Ann Behav Med Publ Soc Behav Med, vol.28, pp.105-113, 2004.

C. Lanhers, M. Duclos, A. Guttmann, E. Coudeyre, B. Pereira et al., General Practitioners' Barriers to Prescribe Physical Activity: The Dark Side of the Cluster Effects on the Physical Activity of Their Type 2 Diabetes Patients, PloS One, vol.10, p.140429, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01241710

M. Duclos, S. Dejager, N. Postel-vinay, S. Di-nicola, S. Quéré et al., Physical activity in patients with type 2 diabetes and hypertension--insights into motivations and barriers from the MOBILE study, Vasc Health Risk Manag, vol.11, pp.361-371, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01216249

W. Demark-wahnefried, E. C. Clipp, I. M. Lipkus, D. Lobach, D. C. Snyder et al., Main Outcomes of the FRESH START Trial: A Sequentially Tailored, Diet and Exercise Mailed Print Intervention Among Breast and Prostate Cancer Survivors, J Clin Oncol, vol.25, pp.2709-2718, 2007.

B. M. Pinto, G. M. Frierson, C. Rabin, J. J. Trunzo, and B. H. Marcus, Home-based physical activity intervention for breast cancer patients, J Clin Oncol Off J Am Soc Clin Oncol, vol.23, pp.3577-3587, 2005.

W. Demark-wahnefried, M. C. Morey, E. C. Clipp, C. F. Pieper, D. C. Snyder et al., Leading the Way in Exercise and Diet (Project LEAD): intervening to improve function among older breast and prostate cancer survivors, Control Clin Trials, vol.24, pp.206-223, 2003.

C. Rabin, N. Simpson, K. Morrow, and B. Pinto, Behavioral and psychosocial program needs of young adult cancer survivors, Qual Health Res, vol.21, pp.796-806, 2011.

A. D. Goode, S. P. Lawler, C. L. Brakenridge, M. M. Reeves, and E. G. Eakin, Telephone, print, and Web-based interventions for physical activity, diet, and weight control among cancer survivors: a systematic review, J Cancer Surviv Res Pract, vol.9, pp.660-682, 2015.

A. Hatchett, J. S. Hallam, and M. A. Ford, Evaluation of a social cognitive theory-based email intervention designed to influence the physical activity of survivors of breast cancer, Psychooncology, vol.22, pp.829-836, 2013.

C. H. Kroenke, W. Y. Chen, B. Rosner, and M. D. Holmes, Weight, weight gain, and survival after breast cancer diagnosis, J Clin Oncol. 1 mars, vol.23, issue.7, pp.1370-1378, 2005.

B. J. Caan, M. L. Kwan, G. Hartzell, A. Castillo, M. L. Slattery et al., Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer, Cancer Causes Control. déc, vol.19, issue.10, pp.1319-1347, 2008.

N. S. Mutschler, C. Scholz, T. Friedl, T. Zwingers, P. A. Fasching et al., Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study, Clinical Breast Cancer. 1 avr, vol.18, issue.2, pp.175-83, 2018.

É. Gadéa, É. Thivat, Q. Wang-lopez, M. Viala, R. Paulon et al., Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms

, Bull Cancer. sept, vol.100, issue.9, pp.865-70, 2013.

W. Demark-wahnefried, B. K. Rimer, and E. P. Winer, Weight gain in women diagnosed with breast cancer, J Am Diet Assoc. mai, vol.97, issue.5, pp.527-535, 1997.

W. Demark-wahnefried, B. L. Peterson, E. P. Winer, L. Marks, N. Aziz et al., Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy, J Clin Oncol. 1 mai, vol.19, issue.9, pp.2381-2390, 2001.

N. Saquib, S. W. Flatt, L. Natarajan, C. A. Thomson, W. A. Bardwell et al., Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study. Breast Cancer Res Treat, vol.105, pp.177-86, 2007.

E. Gadéa, E. Thivat, E. Planchat, B. Morio, and X. Durando, Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms, Obes Rev. avr, vol.13, issue.4, pp.368-80, 2012.

W. Demark-wahnefried, V. Hars, M. R. Conaway, K. Havlin, B. K. Rimer et al., Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy, Am J Clin Nutr. mai, vol.65, issue.5, pp.1495-501, 1997.

M. N. Harvie, I. T. Campbell, A. Baildam, and A. Howell, Energy balance in early breast cancer patients receiving adjuvant chemotherapy, Breast Cancer Res Treat. févr, vol.83, issue.3, pp.201-211, 2004.

T. Bargut, M. B. Aguila, and C. A. Mandarim-de-lacerda, Brown adipose tissue: Updates in cellular and molecular biology, Tissue Cell, vol.48, issue.5, pp.452-60, 2016.

D. Richard and F. Picard, Brown fat biology and thermogenesis, Front Biosci (Landmark Ed). 1 janv, vol.16, pp.1233-60, 2011.

B. B. Lowell, S. -susulic, V. Hamann, A. Lawitts, J. A. Himms-hagen et al., Development of obesity in transgenic mice after genetic ablation of brown adipose tissue, Nature. 23 déc, vol.366, issue.6457, pp.740-742, 1993.

H. M. Feldmann, V. Golozoubova, B. Cannon, and J. Nedergaard, UCP1 ablation induces obesity and abolishes dietinduced thermogenesis in mice exempt from thermal stress by living at thermoneutrality, Cell Metab. févr, vol.9, issue.2, pp.203-212, 2009.

F. J. Ong, B. A. Ahmed, S. M. Oreskovich, D. P. Blondin, T. Haq et al., Recent advances in the detection of brown adipose tissue in adult humans: a review, Clin Sci. 31 mai, vol.132, issue.10, pp.1039-54, 2018.

J. Nedergaard, T. Bengtsson, and B. Cannon, Three years with adult human brown adipose tissue, Ann N Y Acad Sci, vol.1212, pp.20-36, 2010.

A. M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman et al., Identification and importance of brown adipose tissue in adult humans, N Engl J Med. 9 avr, vol.360, issue.15, pp.1509-1526, 2009.

K. A. Virtanen, M. E. Lidell, J. Orava, M. Heglind, R. Westergren et al., Functional brown adipose tissue in healthy adults, N Engl J Med. 9 avr, vol.360, issue.15, pp.1518-1543, 2009.

G. J. Cook, I. Fogelman, and M. N. Maisey, Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation, Semin Nucl Med, vol.26, issue.4, pp.308-322, 1996.

C. Cohade, M. Osman, H. K. Pannu, and R. L. Wahl, Uptake in supraclavicular area fat (« USA-Fat »): description on 18F-FDG PET/CT, J Nucl Med. févr, vol.44, issue.2, pp.170-176, 2003.

E. M. Rohren, T. G. Turkington, and R. E. Coleman, Clinical applications of PET in oncology, Radiology. mai, vol.231, issue.2, pp.305-337, 2004.

J. Nedergaard, T. Bengtsson, and B. Cannon, Unexpected evidence for active brown adipose tissue in adult humans, Am J Physiol Endocrinol Metab. août, vol.293, issue.2, pp.444-452, 2007.

H. Engel, H. Steinert, A. Buck, T. Berthold, H. Böni et al., Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations, J Nucl Med. mars, vol.37, issue.3, pp.441-447, 1996.

E. Gadea, E. Thivat, C. Merlin, R. Paulon, F. Kwiatkowski et al., Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study, Nutr Cancer, vol.66, issue.7, pp.1092-1098, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859019

C. Rousseau, E. Bourbouloux, L. Campion, N. Fleury, B. Bridji et al., Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans, Eur J Nucl Med Mol Imaging. juill, vol.33, issue.7, pp.785-91, 2006.

L. Bahler, F. Holleman, J. Booij, J. B. Hoekstra, and H. J. Verberne, Interobserver and intraobserver variability for the assessment of brown adipose tissue activity on 18F-FDG PET-CT, Nucl Med Commun. avr, vol.37, issue.4, pp.363-71, 2016.

T. F. Hany, E. Gharehpapagh, E. M. Kamel, A. Buck, J. Himms-hagen et al., Brown adipose tissue: a factor to consider in symmetrical tracer uptake in the neck and upper chest region, Eur J Nucl Med Mol Imaging, vol.29, issue.10, pp.1393-1401, 2002.

P. J. Goodwin, M. Ennis, K. I. Pritchard, D. Mccready, J. Koo et al., Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis, J Clin Oncol. janv, vol.17, issue.1, pp.120-129, 1999.

E. Thivat, S. Thérondel, O. Lapirot, C. Abrial, P. Gimbergues et al., Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse, BMC Cancer, vol.25, p.648, 2010.
URL : https://hal.archives-ouvertes.fr/inserm-00663871

G. Makari-judson, C. H. Judson, and W. C. Mertens, Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year, Breast J. juin, vol.13, issue.3, pp.258-65, 2007.

E. Gadéa, E. Thivat, P. Dubray-longeras, M. Arbre, I. Van-praagh et al., Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes, Nutr Cancer. 20 sept, pp.1-10, 2018.

W. H. Heideman, N. S. Russell, C. Gundy, M. A. Rookus, and D. W. Voskuil, The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors, Eur J Cancer. janv, vol.45, issue.1, pp.119-145, 2009.

M. L. Irwin, A. Mctiernan, R. N. Baumgartner, K. B. Baumgartner, L. Bernstein et al., Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors, J Clin Oncol. 1 févr, vol.23, issue.4, pp.774-82, 2005.

C. L. Rock, S. W. Flatt, V. Newman, B. J. Caan, M. N. Haan et al., Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group, J Am Diet Assoc, vol.99, issue.10, pp.1212-1233, 1999.

O. Trédan, A. Bajard, A. Meunier, P. Roux, I. Fiorletta et al., Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study, Clin Nutr. avr, vol.29, issue.2, pp.187-91, 2010.

R. M. Winkels, S. Beijer, R. Van-lieshout, D. Van-barneveld, J. Hofstede et al., Changes in body weight during various types of chemotherapy in breast cancer patients, Journal. févr, vol.9, issue.1, pp.39-44, 2014.

A. L. Green, U. Bagci, S. Hussein, P. V. Kelly, R. Muzaffar et al., Brown adipose tissue detected by PET/CT imaging is associated with less central obesity, Nucl Med Commun. juill, vol.38, issue.7, pp.629-664, 2017.

R. Bibliographiques,

B. E. Ainsworth, W. L. Haskell, M. C. Whitt, M. L. Irwin, A. M. Swartz et al., Compendium of physical activities: an update of activity codes and MET intensities, Med. Sci. Sports Exerc. septembre, vol.32, pp.498-504, 2000.

K. G. Alberti, R. H. Eckel, S. M. Grundy, P. Z. Zimmet, J. I. Cleeman et al., International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, International Atherosclerosis Society

, National Heart, Lung, and Blood Institute, American Heart Association; World Heart Federation

, International Atherosclerosis Society; and International Association for the Study of Obesity, vol.120, pp.1640-1645, 2009.

M. Alligier, K. Seyssel, E. Disse, and M. Laville, Le tissu adipeux: couleur, localisation, fonctions et autres données nouvelles, 2013.

A. Aslani, R. C. Smith, B. J. Allen, N. Pavlakis, and J. A. Levi, « Changes in body composition during breast cancer chemotherapy with the CMF-regimen, Breast Cancer Res. Treat. octobre, vol.57, pp.285-290, 1999.

C. Atalay and A. ?. Küçük, « The impact of weight gain during adjuvant chemotherapy on survival in breast cancer ». Ulus. Cerrahi Derg, vol.31, pp.124-127, 2015.

D. A. Barrière, J. Rieusset, D. Chanteranne, J. Busserolles, M. Chauvin et al., « Paclitaxel therapy potentiates cold hyperalgesia in streptozotocin-induced diabetic rats through enhanced mitochondrial reactive oxygen species production and TRPA1 sensitization, vol.153, pp.553-561, 2012.

S. F. Barrington and M. N. Maisey, Skeletal muscle uptake of fluorine-18-FDG: effect of oral diazepam », J. Nucl. Med. Off. Publ. Soc. Nucl. Med. juillet, vol.37, pp.1127-1129, 1996.

G. Basaran, N. S. Turhal, D. Cabuk, N. Yurt, G. Yurtseven et al., Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey, Med. Oncol. Northwood Lond. Engl, vol.28, pp.409-415, 2011.

S. Battisti, F. M. Guida, F. Coppa, D. M. Vaccaro, D. Santini et al., « Modification of abdominal fat distribution after aromatase inhibitor therapy in breast cancer patients visualized using 3-D computed tomography volumetry, Clin. Breast Cancer, vol.14, pp.365-370, 2014.

M. Baum, A. U. Budzar, J. Cuzick, J. Forbes, J. H. Houghton et al., Group. « Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial, Lancet Lond. Engl. 22 juin, vol.359, pp.2131-2139, 2002.
URL : https://hal.archives-ouvertes.fr/hal-00483565

D. Beckwée, L. Leysen, K. Meuwis, and N. Adriaenssens, « Prevalence of aromatase inhibitor-induced arthralgia in breast cancer: a systematic review and meta-analysis ». Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.25, pp.1673-1686, 2017.

M. M. Van-den-berg, R. M. Winkels, J. T. De-kruif, H. W. Van-laarhoven, M. Visser et al., « Weight change during chemotherapy in breast cancer patients: a meta-analysis, BMC Cancer, vol.17, 2017.

M. O. Bernier, G. Plu-bureau, N. Bossard, L. Ayzac, and J. C. Thalabard, Breastfeeding and risk of breast cancer: a metaanalysis of published studies, Hum. Reprod. Update. août, vol.6, pp.374-386, 2000.

F. Berrino, A. Villarini, A. Traina, B. Bonanni, S. Panico et al., « Metabolic syndrome and breast cancer prognosis, Breast Cancer Res. Treat, vol.147, pp.159-165, 2014.

G. Bianchini and L. Gianni, « The immune system and response to HER2-targeted treatment in breast cancer, Lancet Oncol, vol.15, pp.58-68, 2014.

N. Biglia, E. Peano, P. Sgandurra, G. Moggio, S. Pecchio et al., « Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women, Gynecol. Endocrinol. Off. J. Int. Soc. Gynecol. Endocrinol, vol.29, pp.263-267, 2013.

B. R. Bird and S. M. Swain, « Cardiac toxicity in breast cancer survivors: review of potential cardiac problems, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res, vol.14, pp.14-24, 2008.

A. Biswas, P. I. Oh, G. E. Faulkner, R. R. Bajaj, M. A. Silver et al., « Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis, Ann. Intern. Med, vol.162, pp.123-132

P. Björntorp and L. Sjöström, Number and size of adipose tissue fat cells in relation to metabolism in human obesity, vol.20, pp.703-713, 1971.

C. M. Blanchard, K. S. Courneya, and K. Stein, American Cancer Society's SCS-II. « Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.2198-2204, 2008.

A. Boltong, S. Aranda, R. Keast, R. Wynne, P. A. Francis et al., « A prospective cohort study of the effects of adjuvant breast cancer chemotherapy on taste function, food liking, appetite and associated nutritional outcomes, PloS One, vol.9, p.103512, 2014.

P. Boström, J. Wu, M. P. Jedrychowski, A. Korde, L. Ye et al., « A PGC1-?-dependent myokine that drives brown-fat-like development of white fat and thermogenesis », Nature, vol.481, pp.463-468

E. J. Bowles, R. Wellman, H. S. Feigelson, A. A. Onitilo, A. N. Freedman et al., Pharmacovigilance Study Team. « Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study, J. Natl. Cancer Inst, vol.104, pp.1293-1305

J. Brandt, J. P. Garne, I. Tengrup, and J. Manjer, « Age at diagnosis in relation to survival following breast cancer: a cohort study, World J. Surg. Oncol, vol.13, p.33

B. Thürlimann, A. Keshaviah, A. S. Coates, H. Mouridsen, L. Mauriac et al., Goldhirsch A. « A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer, Breast International Group (BIG) 1-98 Collaborative Group, vol.353, pp.2747-2757, 2005.

L. A. Brinton, C. Schairer, R. N. Hoover, and J. F. Fraumeni, Menstrual factors and risk of breast cancer, Cancer Invest, vol.6, pp.245-254, 1988.

A. Brønstad, A. Berg, and R. K. Reed, Effects of the taxanes paclitaxel and docetaxel on edema formation and interstitial fluid pressure, Am. J. Physiol. Heart Circ. Physiol, vol.287, pp.963-968, 2004.

R. W. Brown, C. D. Allred, G. M. Clark, C. K. Osborne, and S. G. Hilsenbeck, Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer, Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res. mars, vol.2, pp.585-592, 1996.

M. Bulló, P. García-lorda, I. Megias, and J. Salas-salvadó, Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression, Obes. Res, vol.11, pp.525-531, 2003.

B. J. Caan, J. A. Emond, L. Natarajan, A. Castillo, E. P. Gunderson et al., « Post-diagnosis weight gain and breast cancer recurrence in women with early stage breast cancer, Breast Cancer Res. Treat, vol.99, pp.47-57, 2006.

B. J. Caan, M. L. Kwan, G. Hartzell, A. Castillo, M. L. Slattery et al., « Pre-diagnosis body mass index, post-diagnosis weight change, and prognosis among women with early stage breast cancer ». Cancer Causes Control CCC, vol.19, pp.1319-1328, 2008.

J. K. Camoriano, C. L. Loprinzi, J. N. Ingle, T. M. Therneau, J. E. Krook et al., Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.8, pp.1327-1334, 1990.

K. L. Campbell, K. Lane, A. D. Martin, K. A. Gelmon, and D. C. Mckenzie, Resting energy expenditure and body mass changes in women during adjuvant chemotherapy for breast cancer ». Cancer Nurs, vol.30, pp.95-100, 2007.

M. Carayol, P. Bernard, J. Boiché, F. Riou, B. Mercier et al., « Psychological effect of exercise in women with breast cancer receiving adjuvant therapy: what is the optimal dose needed?, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.24, pp.291-300, 2013.

A. R. Carmichael, Obesity and prognosis of breast cancer », Obes. Rev. Off. J. Int. Assoc. Study Obes, vol.7, pp.333-340, 2006.

C. J. Caspersen, K. E. Powell, and G. M. Christenson, « Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research, Public Health Rep. Wash. DC, vol.100, pp.126-131, 1974.

S. Catalano, S. Marsico, C. Giordano, L. Mauro, P. Rizza et al., « Leptin enhances, via AP-1, expression of aromatase in the MCF-7 cell line, J. Biol. Chem, vol.278, pp.28668-28676, 2003.

F. S. Celi, Brown adipose tissue--when it pays to be inefficient, N. Engl. J. Med, vol.9, pp.1553-1556, 2009.

M. Chandalia, P. Lin, T. Seenivasan, E. H. Livingston, P. G. Snell et al., Abate N. « Insulin resistance and body fat distribution in South Asian men compared to Caucasian men, PloS One, vol.2, p.812, 2007.

L. N. Chaudhary, S. Wen, J. Xiao, A. K. Swisher, S. Kurian et al., « Weight change associated with third-generation adjuvant chemotherapy in breast cancer patients, J. Community Support. Oncol, vol.12, pp.355-360, 2014.

M. Chavez-macgregor, J. Niu, N. Zhang, L. S. Elting, B. D. Smith et al., « Cardiac Monitoring During Adjuvant Trastuzumab-Based Chemotherapy Among Older Patients With Breast Cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.33, pp.2176-2183

B. Chen, X. Peng, L. Pentassuglia, C. C. Lim, and D. B. Sawyer, « Molecular and cellular mechanisms of anthracycline cardiotoxicity, Cardiovasc. Toxicol, vol.7, pp.114-121, 2007.

X. Chen, W. Lu, W. Zheng, K. Gu, Z. Chen et al., Obesity and weight change in relation to breast cancer survival, Breast Cancer Res. Treat, vol.122, pp.823-833, 2010.

Y. Chen, R. Semenciw, E. Kliewer, Y. Shi, and Y. Mao, « Incidence of second primary breast cancer among women with a first primary in Manitoba, Canada ». Breast Cancer Res. Treat. mai, vol.67, pp.35-40, 2001.

R. T. Chlebowski, E. Aiello, and A. Mctiernan, « Weight loss in breast cancer patient management, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.15, issue.2002, pp.1128-1143

F. Clavel-chapelon and M. Gerber, « Reproductive factors and breast cancer risk. Do they differ according to age at diagnosis? », Breast Cancer Res. Treat. mars, vol.72, pp.107-115, 2002.

M. P. Cleary, M. E. Grossmann, and . Minireview, Obesity and breast cancer: the estrogen connection, vol.150, pp.2537-2542, 2009.

M. A. Cobleigh, C. L. Vogel, D. Tripathy, N. J. Robert, S. Scholl et al., « Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.17, pp.2639-2648, 1999.

G. A. Colditz, W. C. Willett, D. J. Hunter, M. J. Stampfer, J. E. Manson et al., A. « Family history, age, and risk of breast cancer. Prospective data from the Nurses' Health Study, vol.270, pp.338-343, 1993.

, Collaborative Group on Hormonal Factors in Breast Cancer. « Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease, Lancet Lond. Engl, vol.360, pp.187-195, 2002.

, Collaborative Group on Hormonal Factors in Breast Cancer. « Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies, Lancet Lond. Engl, vol.22, issue.1996, pp.1713-1727

T. Cornette, F. Vincent, S. Mandigout, M. T. Antonini, S. Leobon et al., « Effects of home-based exercise training on VO2 in breast cancer patients under adjuvant or neoadjuvant chemotherapy (SAPA): a randomized controlled trial, Eur. J. Phys. Rehabil. Med. avril, vol.52, pp.223-232, 2016.

E. J. Coups and J. S. Ostroff, A population-based estimate of the prevalence of behavioral risk factors among adult cancer survivors and noncancer controls, Prev. Med, vol.40, pp.702-711, 2005.

K. S. Courneya, R. J. Segal, J. R. Mackey, K. Gelmon, R. D. Reid et al., Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: a multicenter randomized controlled trial, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.4396-4404, 2007.

K. S. Courneya, R. J. Segal, J. R. Vallerand, C. C. Forbes, J. J. Crawford et al., Motivation for Different Types and Doses of Exercise During Breast Cancer Chemotherapy: a Randomized Controlled Trial, Ann. Behav. Med. Publ. Soc. Behav. Med, vol.50, pp.554-563, 2016.

P. Cremoux, . De, and J. Extra, Les inhibiteurs de l'aromatase : pharmacologie et activité clinique ». Médecine Thérapeutique Endocrinol. 23 janvier, vol.2, pp.518-543, 2001.

A. M. Cypess, S. Lehman, G. Williams, I. Tal, D. Rodman et al., « Identification and importance of brown adipose tissue in adult humans, N. Engl. J. Med, vol.9, pp.1509-1517, 2009.

I. J. Dahabreh, H. Linardou, F. Siannis, G. Fountzilas, and S. Murray, « Trastuzumab in the adjuvant treatment of early-stage breast cancer: a systematic review and meta-analysis of randomized controlled trials ». The Oncologist, vol.13, pp.620-630, 2008.

L. Dal-maso, A. Zucchetto, R. Talamini, D. Serraino, C. F. Stocco et al., Prospective Analysis of Case-control studies on Environmental factors and health (PACE) study group. « Effect of obesity and other lifestyle factors on mortality in women with breast cancer », Int. J. Cancer, vol.123, pp.2188-2194, 2008.

G. V. Dall and K. L. Britt, Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk ». Front. Oncol, vol.7, 2017.

C. Davies, H. Pan, J. Godwin, R. Gray, R. Arriagada et al., Longer Against Shorter (ATLAS) Collaborative Group. « Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial, vol.9, pp.805-816, 2013.

D. Keulenaer, G. W. Doggen, K. Lemmens, and K. , « The vulnerability of the heart as a pluricellular paracrine organ: lessons from unexpected triggers of heart failure in targeted ErbB2 anticancer therapy, Circ. Res, vol.8, issue.2010, pp.35-46

M. De-laurentiis, G. Cancello, D. D'agostino, M. Giuliano, A. Giordano et al., « Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.44-53, 2008.

V. De-luca, C. Minganti, P. Borrione, E. Grazioli, C. Cerulli et al., « Effects of concurrent aerobic and strength training on breast cancer survivors: a pilot study, vol.136, pp.126-132, 2016.

W. Demark-wahnefried, V. Hars, M. R. Conaway, K. Havlin, B. K. Rimer et al., « Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy, Am. J. Clin. Nutr. mai, vol.65, pp.1495-1501, 1997.

W. Demark-wahnefried, V. Hars, M. R. Conaway, K. Havlin, B. K. Rimer et al., Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy, Am. J. Clin. Nutr, vol.65, pp.1495-1501, 1997.

W. Demark-wahnefried, A. J. Kenyon, P. Eberle, A. Skye, and W. E. Kraus, Preventing sarcopenic obesity among breast cancer patients who receive adjuvant chemotherapy: results of a feasibility study, Clin. Exerc. Physiol. février, vol.4, pp.44-49, 2002.

W. Demark-wahnefried, B. L. Peterson, E. P. Winer, L. Marks, N. Aziz et al., Changes in weight, body composition, and factors influencing energy balance among premenopausal breast cancer patients receiving adjuvant chemotherapy, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.19, pp.2381-2389, 2001.

W. Demark-wahnefried, B. K. Rimer, and E. P. Winer, Weight gain in women diagnosed with breast cancer, J. Am. Diet. Assoc. mai, vol.97, pp.527-528, 1997.

C. A. Denysschen, J. K. Brown, M. H. Cho, and M. J. Dodd, Nutritional symptom and body composition outcomes of aerobic exercise in women with breast cancer, Clin. Nurs. Res, vol.20, pp.29-46, 2011.

D. T. Dibaba, K. Ogunsina, D. Braithwaite, and T. Akinyemiju, « Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype », Breast Cancer Res. Treat, 2018.

C. M. Dieli-conwright, L. Wong, S. Waliany, L. Bernstein, B. Salehian et al., An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy ». Cancer, vol.122, pp.2646-2653

L. Doussal, V. Tubiana-hulin, M. Hacene, K. Friedman, S. Brunet et al., « Nuclear characteristics as indicators of prognosis in node negative breast cancer patients, Breast Cancer Res. Treat. novembre, vol.14, pp.207-216, 1989.

C. Doyle, L. H. Kushi, T. Byers, K. S. Courneya, W. Demark-wahnefried et al., « Nutrition and physical activity during and after cancer treatment: an American Cancer Society guide for informed choices, Nutrition, Physical Activity and Cancer Survivorship Advisory Committee, vol.56, pp.323-353, 2006.

N. Druesne-pecollo, M. Touvier, E. Barrandon, D. S. Chan, T. Norat et al., Excess body weight and second primary cancer risk after breast cancer: a systematic review and meta-analysis of prospective studies, Breast Cancer Res. Treat, vol.135, pp.647-654, 2012.

V. Dubois, T. Jardé, L. Delort, H. Billard, D. Bernard-gallon et al., Caldefie-Chezet F. « Leptin induces a proliferative response in breast cancer cells but not in normal breast cells, Nutr. Cancer, vol.66, pp.645-655, 2014.

S. F. Duijts, M. M. Faber, H. S. Oldenburg, M. Van-beurden, and N. K. Aaronson, Effectiveness of behavioral techniques and physical exercise on psychosocial functioning and health-related quality of life in breast cancer patients and survivors--a meta-analysis ». Psychooncology, vol.20, pp.115-126, 2011.

L. K. Dunnwald, M. A. Rossing, and C. I. Li, Hormone receptor status, tumor characteristics, and prognosis: a prospective cohort of breast cancer patients, Breast Cancer Res. BCR

E. G. Eakin, D. R. Youlden, P. D. Baade, S. P. Lawler, M. M. Reeves et al., « Health behaviors of cancer survivors: data from an Australian population-based survey ». Cancer Causes Control CCC, vol.18, pp.881-894, 2007.

, « Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials, Lancet Lond. Engl, vol.14, issue.2005, pp.1687-1717

, « Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials, Lancet Lond. Engl, vol.386, pp.1341-1352, 2015.

R. H. Eckel, S. M. Grundy, and P. Z. Zimmet, The metabolic syndrome, Lancet Lond. Engl, vol.16, pp.1415-1428, 2005.

C. W. Elston and I. O. Ellis, « Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up, vol.19, pp.403-410, 1991.

H. Engel, H. Steinert, A. Buck, T. Berthold, H. Böni et al., Von Schulthess G. K. « Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations, J. Nucl. Med. Off. Publ. Soc. Nucl. Med. mars, vol.37, pp.441-446, 1996.

, Environnement et santé / Rapports et synthèses / Publications et outils / Accueil, Étude de santé sur l'environnement, la biosurveillance, l'activité physique et la nutrition (Esteban), 2014.

M. Ewertz, M. Jensen, K. Á. Gunnarsdóttir, I. Højris, E. H. Jakobsen et al., Cold S. « Effect of obesity on prognosis after early-stage breast cancer, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.29, pp.25-31, 2011.

A. S. Fairey, K. S. Courneya, C. J. Field, G. J. Bell, L. W. Jones et al., Effects of exercise training on fasting insulin, insulin resistance, insulin-like growth factors, and insulin-like growth factor binding proteins in postmenopausal breast cancer survivors: a randomized controlled trial, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. août, vol.12, pp.721-727, 2003.

J. C. Fehrenbacher, Chemotherapy-induced peripheral neuropathy, Prog. Mol. Biol. Transl. Sci, vol.131, pp.471-508, 2015.

H. M. Feldmann, V. Golozoubova, B. Cannon, and J. Nedergaard, « UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality ». Cell Metab, vol.9, pp.203-209, 2009.

T. Ferguson, N. Wilcken, R. Vagg, D. Ghersi, and A. K. Nowak, « Taxanes for adjuvant treatment of early breast cancer, Cochrane Database Syst. Rev, p.4421

B. Fisher, J. Costantino, C. Redmond, R. Poisson, D. Bowman et al., A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors, N. Engl. J. Med, vol.320, pp.479-484

B. Fisher, J. Dignam, J. Bryant, A. Decillis, D. L. Wickerham et al., « Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors, J. Natl. Cancer Inst. 6 novembre, vol.88, pp.1529-1542, 1996.

P. L. Fitzgibbons, D. L. Page, D. Weaver, A. D. Thor, D. C. Allred et al., Prognostic Factors in Breast Cancer, Arch. Pathol. Lab. Med, vol.124, pp.966-978, 2000.

S. J. Flatters and G. J. Bennett, « Studies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunction, vol.122, pp.245-257, 2006.

A. Foucaut, S. E. Berthouze, M. Touillaud, M. Morelle, V. Bourne-branchu et al., « Deterioration of Physical Activity Level and Metabolic Risk Factors After Early-Stage Breast Cancer Diagnosis ». Cancer Nurs, vol.38, pp.1-9, 2015.

A. Foucaut, S. E. Berthouze-aranda, M. Touillaud, A. Kempf-lépine, C. Baudinet et al., « Reduction of health risk factors through an adapted physical activity program in patients with breast cancer ». Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.22, pp.1097-1104, 2014.

G. Francini, R. Petrioli, A. Montagnani, A. Cadirni, S. Campagna et al., Exemestane after tamoxifen as adjuvant hormonal therapy in postmenopausal women with breast cancer: effects on body composition and lipids, vol.17, pp.153-158

R. J. Freedman, N. Aziz, D. Albanes, T. Hartman, D. Danforth et al., « Weight and body composition changes during and after adjuvant chemotherapy in women with breast cancer, J. Clin. Endocrinol. Metab, vol.89, pp.2248-2253, 2004.

C. M. Friedenreich, H. K. Neilson, and B. M. Lynch, « State of the epidemiological evidence on physical activity and cancer prevention », Eur. J. Cancer Oxf. Engl, vol.46, pp.2593-2604, 1990.

C. M. Friedenreich, H. K. Neilson, R. O'reilly, A. Duha, Y. Yasui et al., Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women: A Randomized Clinical Trial, JAMA Oncol, vol.1, pp.766-776, 2015.

S. J. Fuller, K. Sivarajah, and P. H. Sugden, ErbB receptors, their ligands, and the consequences of their activation and inhibition in the myocardium, J. Mol. Cell. Cardiol, vol.44, pp.831-854, 2008.

A. C. Furmaniak, M. Menig, and M. H. Markes, Exercise for women receiving adjuvant therapy for breast cancer, Cochrane Database Syst. Rev, vol.9, p.5001

E. Gadéa, E. Thivat, P. Dubray-longeras, M. Arbre, I. Van-praagh et al., « Prospective Study on Body Composition, Energy Balance and Biological Factors Changes in Post-menopausal Women with Breast Cancer Receiving Adjuvant Chemotherapy Including Taxanes, Nutr. Cancer, pp.1-10, 2018.

E. Gadea, E. Thivat, C. Merlin, R. Paulon, F. Kwiatkowski et al., « Brown adipose tissue activity in relation to weight gain during chemotherapy in breast cancer patients: a pilot study, Nutr. Cancer, vol.66, pp.1092-1096, 2014.

E. Gadea, E. Thivat, R. Paulon, F. Mishellany, P. Gimbergues et al., « Hibernoma: a clinical model for exploring the role of brown adipose tissue in the regulation of body weight?, J. Clin. Endocrinol. Metab, vol.99, pp.1-6, 2014.

E. Gadéa, E. Thivat, E. Planchat, B. Morio, and X. Durando, « Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms, Obes. Rev. Off. J. Int. Assoc. Study Obes, vol.13, pp.368-380, 2012.

É. Gadéa, É. Thivat, Q. Wang-lopez, M. Viala, R. Paulon et al., Poor prognostic value of weight change during chemotherapy in non-metastatic breast cancer patients: causes, mechanisms involved and preventive strategies] », Bull. Cancer, vol.100, pp.865-870, 2013.

C. Gajdos, P. I. Tartter, I. J. Bleiweiss, C. Bodian, and S. T. Brower, Stage 0 to stage III breast cancer in young women, J. Am. Coll. Surg. mai, vol.190, pp.523-529, 2000.

W. G. Gathirua-mwangi, T. W. Zollinger, M. J. Murage, K. R. Pradhan, and V. L. Champion, Adult BMI change and risk of Breast Cancer: National Health and Nutrition Examination Survey (NHANES) 2005-2010 ». Breast Cancer Tokyo Jpn, vol.22, pp.648-656, 2015.

J. M. Gierisch, R. R. Coeytaux, R. P. Urrutia, L. J. Havrilesky, P. G. Moorman et al., Oral Contraceptive Use and Risk of Breast, Cervical, Colorectal, and Endometrial Cancers: A Systematic Review, Cancer Epidemiol. Prev. Biomark, vol.22, pp.1931-1943

L. A. Gilliam, K. H. Fisher-wellman, C. Lin, J. M. Maples, B. L. Cathey et al., The anticancer agent doxorubicin disrupts mitochondrial energy metabolism and redox balance in skeletal muscle ». Free Radic, Biol. Med, vol.65, pp.988-996

G. M. Gjerset, S. D. Fosså, K. S. Courneya, E. Skovlund, and L. Thorsen, « Exercise behavior in cancer survivors and associated factors, J. Cancer Surviv. Res. Pract, vol.5, pp.35-43, 2011.

P. J. Goodwin, M. Ennis, K. I. Pritchard, D. Mccready, J. Koo et al., Adjuvant treatment and onset of menopause predict weight gain after breast cancer diagnosis, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.17, pp.120-129, 1999.

P. J. Goodwin, M. Ennis, K. I. Pritchard, M. E. Trudeau, J. Koo et al., « Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.20, pp.42-51, 2002.

P. J. Goodwin, T. Panzarella, and N. F. Boyd, Weight gain in women with localized breast cancer--a descriptive study, Breast Cancer Res. Treat. avril, vol.11, pp.59-66, 1988.

A. L. Green, U. Bagci, S. Hussein, P. V. Kelly, R. Muzaffar et al., Brown adipose tissue detected by PET/CT imaging is associated with less central obesity », Nucl. Med. Commun, vol.38, pp.629-635, 2017.

S. M. Grybach, L. Z. Polishchuk, and V. F. Chekhun, Analysis of the survival of patients with breast cancer depending on age, molecular subtype of tumor and metabolic syndrome, Exp. Oncol. octobre, vol.40, pp.243-248, 2018.

B. A. Guigni, D. M. Callahan, T. W. Tourville, M. S. Miller, B. Fiske et al., SKELETAL MUSCLE ATROPHY AND DYSFUNCTION IN BREAST CANCER PATIENTS: ROLE FOR CHEMOTHERAPY-DERIVED OXIDANT STRESS, 2018.

S. Guo, R. R. Gonzalez-perez, and . Notch, IL-1 and leptin crosstalk outcome (NILCO) is critical for leptininduced proliferation, migration and VEGF/VEGFR-2 expression in breast cancer, PloS One, vol.6, p.21467, 2011.

P. C. Hannaford, S. Selvaraj, A. M. Elliott, V. Angus, L. Iversen et al., « Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study, BMJ, vol.335, p.651, 2007.

D. Harari and Y. Yarden, « Molecular mechanisms underlying ErbB2/HER2 action in breast cancer, vol.19, pp.6102-6114, 2000.

M. Harms and P. Seale, « Brown and beige fat: development, function and therapeutic potential, Nat. Med, vol.19, pp.1252-1263, 2013.

S. Harrison, S. C. Hayes, and B. Newman, « Level of physical activity and characteristics associated with change following breast cancer diagnosis and treatment, vol.18, pp.387-394, 2009.

M. N. Harvie, I. T. Campbell, A. Baildam, and A. Howell, Energy balance in early breast cancer patients receiving adjuvant chemotherapy, vol.83, pp.201-210, 2004.

M. N. Harvie, I. T. Campbell, A. Baildam, and A. Howell, Energy balance in early breast cancer patients receiving adjuvant chemotherapy, vol.83, pp.201-210, 2004.

M. J. Haykowsky, J. R. Mackey, R. B. Thompson, L. W. Jones, and D. I. Paterson, Adjuvant Trastuzumab Induces Ventricular Remodeling Despite Aerobic Exercise Training, Clin. Cancer Res

W. H. Heideman, N. S. Russell, C. Gundy, M. A. Rookus, and D. W. Voskuil, « The frequency, magnitude and timing of post-diagnosis body weight gain in Dutch breast cancer survivors, Eur. J. Cancer Oxf. Engl, vol.45, pp.119-126, 1990.

P. A. Henriksen, Anthracycline cardiotoxicity: an update on mechanisms, monitoring and prevention, vol.104, pp.971-977, 2018.

A. Henriksson, C. Arving, B. Johansson, H. Igelström, and K. Nordin, « Perceived barriers to and facilitators of being physically active during adjuvant cancer treatment, vol.99, pp.1220-1226, 2016.

K. Hojan, P. Milecki, M. Moli?ska-glura, A. Roszak, and P. Leszczy?ski, « Effect of physical activity on bone strength and body composition in breast cancer premenopausal women during endocrine therapy, Eur. J. Phys. Rehabil. Med. juin, vol.49, pp.331-339, 2013.

C. N. Holick, P. A. Newcomb, A. Trentham-dietz, L. Titus-ernstoff, A. J. Bersch et al., Physical activity and survival after diagnosis of invasive breast cancer, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.17, pp.379-386, 2008.

M. D. Holmes, W. Y. Chen, D. Feskanich, C. H. Kroenke, and G. Colditz, A. « Physical activity and survival after breast cancer diagnosis, JAMA, vol.25, issue.2005, pp.2479-2486
URL : https://hal.archives-ouvertes.fr/in2p3-00006511

C. Honthâas and P. Ritz, Ann. Endocrinol. décembre, vol.63, pp.30-37, 2002.

W. E. Hornsby, P. S. Douglas, M. J. West, A. A. Kenjale, A. R. Lane et al., Safety and efficacy of aerobic training in operable breast cancer patients receiving neoadjuvant chemotherapy: a phase II randomized trial, vol.53, pp.65-74, 2014.

A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett et al., Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer, Results of the ATAC (Arimidex, Tamoxifen, vol.365, pp.60-62, 2005.

C. Hsieh, M. Pavia, M. Lambe, S. J. Lan, G. A. Colditz et al., Dual effect of parity on breast cancer risk », Eur. J. Cancer Oxf. Engl, vol.30, pp.969-973, 1990.

A. M. Husebø, B. Karlsen, H. Allan, J. A. Søreide, and E. Bru, « Factors perceived to influence exercise adherence in women with breast cancer participating in an exercise programme during adjuvant chemotherapy: a focus group study, J. Clin. Nurs, vol.24, pp.500-510, 2015.

K. Hwang, Y. A. Kim, J. Kim, A. J. Chu, J. H. Chang et al., The influences of peritumoral lymphatic invasion and vascular invasion on the survival and recurrence according to the molecular subtypes of breast cancer, Breast Cancer Res. Treat, vol.163, pp.71-82, 2017.

, Global Cancer Observatory, 2018.

. Iarc, Alcohol consumption and ethyl carbamate, Iarc Monogr. Eval. Carcinog. Risks Hum. 2010, vol.96, pp.3-1383

E. M. Ibrahim, Al-Homaidh A. « Physical activity and survival after breast cancer diagnosis: metaanalysis of published studies, Med. Oncol. Northwood Lond. Engl, vol.28, pp.753-765, 2011.

E. M. Ibrahim, Al-Homaidh A. « Physical activity and survival after breast cancer diagnosis: metaanalysis of published studies, vol.28, pp.753-765, 2010.

. Inca, Maladies chroniques et traumatismes / Rapports et synthèses / Publications et outils / Accueil ». 2017a. Disponible sur, 2017.

. Inca, Nutrition et prévention primaire des cancers : actualisation des données, 2015.

. Inca and . Objectif, Réduire les risques de séquelles et de second cancer -Les 17 objectifs du Plan | Institut National Du Cancer, vol.8, 2014.

. Inca, Plan cancer 2014-2019 : priorités et objectifs -Plan cancer, 2015.

. Inca, Bénéfices de l'activité physique pendant et après un cancer, 2017.

C. Ingram and J. K. Brown, « Patterns of weight and body composition change in premenopausal women with early stage breast cancer: has weight gain been overestimated? ». Cancer Nurs. décembre, vol.27, pp.483-490, 2004.

M. L. Irwin, M. Alvarez-reeves, L. Cadmus, E. Mierzejewski, S. T. Mayne et al., « Exercise improves body fat, lean mass and bone mass in breast cancer survivors, Silver Spring Md, vol.17, pp.1534-1541, 2009.

M. L. Irwin, B. Cartmel, C. P. Gross, E. Ercolano, F. Li et al., « Randomized Exercise Trial of Aromatase Inhibitor-Induced Arthralgia in Breast Cancer Survivors, J. Clin. Oncol

M. L. Irwin, D. Crumley, A. Mctiernan, L. Bernstein, R. Baumgartner et al., Physical activity levels before and after a diagnosis of breast cancer: The Health, Eating, Activity, and Lifestyle (HEAL) Study ». Cancer, vol.97, pp.1746-1757, 2003.

M. L. Irwin, A. Mctiernan, R. N. Baumgartner, K. B. Baumgartner, L. Bernstein et al., BallardBarbash R. « Changes in body fat and weight after a breast cancer diagnosis: influence of demographic, prognostic, and lifestyle factors, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.23, pp.774-782, 2005.

M. L. Irwin, A. Mctiernan, L. Bernstein, F. D. Gilliland, R. Baumgartner et al., Relationship of obesity and physical activity with C-peptide, leptin, and insulin-like growth factors in breast cancer survivors, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.14, pp.2881-2888, 2005.

M. L. Irwin, A. Mctiernan, J. E. Manson, C. A. Thomson, B. Sternfeld et al., « Physical activity and survival in postmenopausal women with breast cancer: results from the women's health initiative, Cancer Prev. Res. Phila. Pa, vol.4, pp.522-529, 2011.

M. L. Irwin, A. W. Smith, A. Mctiernan, R. Ballard-barbash, K. Cronin et al., « Influence of pre-and postdiagnosis physical activity on mortality in breast cancer survivors: the health, eating, activity, and lifestyle study, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.26, pp.3958-3964, 2008.

R. Iwamoto, S. Yamazaki, M. Asakura, S. Takashima, H. Hasuwa et al., « Heparinbinding EGF-like growth factor and ErbB signaling is essential for heart function, Proc. Natl. Acad. Sci. U. S. A, vol.100, pp.3221-3226, 2003.

T. Jardé, S. Perrier, and M. Vasson, Caldefie-Chézet F. « Molecular mechanisms of leptin and adiponectin in breast cancer, Eur. J. Cancer Oxf. Engl, vol.47, pp.33-43, 1990.

Y. W. Jeon, S. T. Lim, H. J. Choi, and Y. J. Suh, Weight change and its impact on prognosis after adjuvant TAC (docetaxel-doxorubicin-cyclophosphamide) chemotherapy in Korean women with nodepositive breast cancer, Med. Oncol. Northwood Lond. Engl, vol.31, p.849, 2014.

S. Jiralerspong and P. J. Goodwin, Obesity and Breast Cancer Prognosis: Evidence, Challenges, and Opportunities, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.10, issue.2016, pp.4203-4216

J. Anna, P. Broberg, J. Anders, and Å. B. Tornberg, Olsson H. « Occupational sedentariness and breast cancer risk, Acta Oncol. Stockh. Swed, vol.56, pp.75-80, 2017.

M. E. Jones, M. J. Schoemaker, L. B. Wright, A. Ashworth, and A. J. Swerdlow, « Smoking and risk of breast cancer in the Generations Study cohort, Breast Cancer Res. BCR, vol.19, p.118, 2017.

P. A. Kern, S. Ranganathan, C. Li, L. Wood, and G. Ranganathan, « Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance », Am. J. Physiol. Endocrinol. Metab, vol.280, pp.745-751, 2001.

E. E. Kershaw and J. S. Flier, Adipose tissue as an endocrine organ, J. Clin. Endocrinol. Metab, vol.89, pp.2548-2556, 2004.

K. M. Khan, A. M. Thompson, S. N. Blair, J. F. Sallis, K. E. Powell et al., « Sport and exercise as contributors to the health of nations, Lancet Lond. Engl, vol.380, pp.59-64

C. Kim, D. Kang, B. A. Smith, and K. Landers, A. « Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy, Cancer Nurs. avril, vol.29, pp.156-165, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00495133

C. Kim, D. Kang, B. A. Smith, and K. Landers, A. « Cardiopulmonary responses and adherence to exercise in women newly diagnosed with breast cancer undergoing adjuvant therapy, Cancer Nurs. avril, vol.29, pp.156-165, 2006.
URL : https://hal.archives-ouvertes.fr/hal-00495133

H. Kitayama, T. Kondo, J. Sugiyama, K. Kurimoto, Y. Nishino et al., « Highsensitive troponin T assay can predict anthracycline-and trastuzumab-induced cardiotoxicity in breast cancer patients ». Breast Cancer Tokyo Jpn, vol.24, pp.774-782, 2017.

M. Koda, M. Sulkowska, L. Kanczuga-koda, K. Jarzabek, and S. Sulkowski, « Expression of leptin and its receptor in female breast cancer in relation with selected apoptotic markers, Folia Histochem. Cytobiol, vol.45, issue.1, pp.187-191, 2007.

G. G. Kolden, T. J. Strauman, A. Ward, J. Kuta, T. E. Woods et al., « A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits, vol.11, pp.447-456, 2002.

C. H. Kroenke, W. Y. Chen, B. Rosner, M. D. Holmes, and . Weight, weight gain, and survival after breast cancer diagnosis, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.23, pp.1370-1378, 2005.

N. Kroman, M. B. Jensen, J. Wohlfahrt, H. T. Mouridsen, P. K. Andersen et al., « Factors influencing the effect of age on prognosis in breast cancer: population based study, BMJ, vol.19, issue.2000, pp.474-478

S. Kuba, R. Fujiyama, K. Yamanouchi, M. Morita, C. Sakimura et al., « Awareness of dysgeusia and gustatory tests in patients undergoing chemotherapy for breast cancer, pp.1-7

N. Kumar, K. A. Allen, D. Riccardi, B. B. Bercu, A. Cantor et al., « Fatigue, weight gain, lethargy and amenorrhea in breast cancer patients on chemotherapy: is subclinical hypothyroidism the culprit?, Breast Cancer Res. Treat, vol.83, pp.149-159, 2004.

M. L. Kwan, B. Sternfeld, I. J. Ergas, A. W. Timperi, J. M. Roh et al., Change in Physical Activity During Active Treatment in a Prospective Study of Breast Cancer Survivors, Breast Cancer Res. Treat, vol.131, pp.679-690, 2012.

B. Ky, M. Putt, H. Sawaya, B. French, J. L. Januzzi et al., Scherrer-Crosbie M. « Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab, J. Am. Coll. Cardiol, vol.63, pp.809-816, 2014.

I. M. Lahart, G. S. Metsios, A. M. Nevill, and A. R. Carmichael, « Physical activity, risk of death and recurrence in breast cancer survivors: A systematic review and meta-analysis of epidemiological studies, Acta Oncol. Stockh. Swed, vol.54, pp.635-654, 2015.

K. J. Lankester, J. E. Phillips, and P. A. Lawton, Weight gain during adjuvant and neoadjuvant chemotherapy for breast cancer: an audit of 100 women receiving FEC or CMF chemotherapy, Clin. Oncol. R. Coll. Radiol. G. B. février, vol.14, pp.64-67, 2002.

H. J. Leach, J. M. Danyluk, and K. C. Nishimura, Culos-Reed S. N. « Benefits of 24 versus 12 weeks of exercise and wellness programming for women undergoing treatment for breast cancer ». Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.24, pp.4597-4606, 2016.

M. E. Lean, W. P. James, G. Jennings, and P. Trayhurn, « Brown adipose tissue uncoupling protein content in human infants, children and adults, Clin. Sci. Lond. Engl, vol.71, pp.291-297, 1979.

J. Lee, Meta-analysis of the Association Between Physical Activity and Breast Cancer Mortality ». Cancer Nurs, 2018.

M. Lee, J. Beith, L. Ward, and S. Kilbreath, « Lymphedema following taxane-based chemotherapy in women with early breast cancer, Lymphat. Res. Biol, vol.12, pp.282-288, 2014.

D. Leroith and C. T. Roberts, « The insulin-like growth factor system and cancer, Cancer Lett, vol.10, issue.2003, pp.127-137

E. G. Levine, J. M. Raczynski, and J. T. Carpenter, Weight gain with breast cancer adjuvant treatment, vol.67, pp.1954-1959, 1991.

J. A. Ligibel, J. Meyerhardt, J. P. Pierce, J. Najita, L. Shockro et al., « Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting, Breast Cancer Res. Treat, vol.132, pp.205-213, 2012.

J. A. Ligibel, A. Partridge, A. Giobbie-hurder, N. Campbell, L. Shockro et al., Physical and psychological outcomes among women in a telephone-based exercise intervention during adjuvant therapy for early stage breast cancer, J. Womens Health, vol.19, pp.1553-1559, 2002.

Y. Liu, N. Nguyen, and G. A. Colditz, Links between alcohol consumption and breast cancer: a look at the evidence ». Womens Health Lond. Engl, vol.11, pp.65-77, 2015.

S. Loi, R. L. Milne, M. L. Friedlander, M. R. Mccredie, G. G. Giles et al., Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.14, pp.1686-1691, 2005.

G. J. Van-londen, S. Perera, K. Vujevich, P. Rastogi, B. Lembersky et al., The impact of an aromatase inhibitor on body composition and gonadal hormone levels in women with breast cancer, Breast Cancer Res. Treat, vol.125, pp.441-446, 2011.

C. L. Loprinzi, K. Maddocks-christianson, S. L. Wolf, R. D. Rao, P. J. Dyck et al., The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism, vol.13, pp.399-403, 2007.

C. L. Loprinzi, B. N. Reeves, S. R. Dakhil, J. A. Sloan, S. L. Wolf et al., Natural history of paclitaxelassociated acute pain syndrome: prospective cohort study NCCTG N08C1, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.29, pp.1472-1478, 2011.

B. B. Lowell, V. S-susulic, A. Hamann, J. A. Lawitts, J. Himms-hagen et al., « Development of obesity in transgenic mice after genetic ablation of brown adipose tissue », Nature, vol.366, pp.740-742, 1993.

E. Luporsi, F. André, F. Spyratos, P. Martin, J. Jacquemier et al.,

D. Cremoux, P. Bellocq, and J. Ki, 67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review, Breast Cancer Res. Treat, vol.132, pp.895-915, 2012.

H. T. Lynch, C. Snyder, and J. Lynch, « Hereditary Breast Cancer: Practical Pursuit for Clinical Translation, Ann. Surg. Oncol, vol.19, pp.1723-1731

M. Quintiliani, L. Mann, D. M. Puputti, M. Quinn, E. Bowen et al., Pilot and Feasibility Test of a Mobile Health-Supported Behavioral Counseling Intervention for Weight Management Among Breast Cancer Survivors ». JMIR Cancer, vol.9, p.4, 2016.

F. Macdiarmid, D. Wang, L. J. Duncan, A. Purohit, M. W. Ghilchick et al., Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha, Mol. Cell. Endocrinol. décembre, vol.106, pp.17-21, 1994.

P. Magni, A. Liuzzi, M. Ruscica, E. Dozio, S. Ferrario et al., « Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin-sensitivity, lipid profile and macronutrient preference, Clin. Endocrinol. (Oxf, vol.62, pp.189-196, 2005.

G. Makari-judson, C. H. Judson, and W. C. Mertens, Longitudinal patterns of weight gain after breast cancer diagnosis: observations beyond the first year », Breast J, vol.13, pp.258-265, 2007.

C. Marant-micallef, Nombre et fractions de cancers attribuables au mode de vie et à l'environnement en France métropolitaine en 2015 : résultats principaux, p.7, 2015.

W. D. Van-marken-lichtenbelt, J. W. Vanhommerig, N. M. Smulders, J. M. Drossaerts, G. J. Kemerink et al., « Cold-activated brown adipose tissue in healthy men, N. Engl. J. Med, vol.9, pp.1500-1508, 2009.

H. L. Mcarthur and S. Chia, « Cardiotoxicity of trastuzumab in clinical practice, N. Engl. J. Med, vol.357, pp.94-95, 2007.

M. L. Mcneely, K. L. Campbell, B. H. Rowe, T. P. Klassen, J. R. Mackey et al., Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis, CMAJ Can. Med. Assoc. J. J. Assoc. Medicale Can, vol.175, issue.4, pp.34-41, 2006.

J. Mcneil, M. S. Farris, Y. Ruan, H. Merry, B. M. Lynch et al., Effects of prescribed aerobic exercise volume on physical activity and sedentary time in postmenopausal women: a randomized controlled trial », Int. J. Behav. Nutr. Phys. Act, vol.15, p.27, 2018.

A. Mctiernan, C. Ulrich, C. Kumai, D. Bean, R. Schwartz et al., Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: results of a pilot study, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol. juin, vol.7, pp.477-481, 1998.

S. Mokuyasu, Y. Suzuki, E. Kawahara, T. Seto, and Y. Tokuda, « High-sensitivity cardiac troponin I detection for 2 types of drug-induced cardiotoxicity in patients with breast cancer ». Breast Cancer Tokyo Jpn, vol.22, pp.563-569, 2015.

A. Montagnani, S. Gonnelli, A. Cadirni, C. Caffarelli, D. Santo et al., « The effects on lipid serum levels of a 2-year adjuvant treatment with exemestane after tamoxifen in postmenopausal women with early breast cancer », Eur. J. Intern. Med, vol.19, pp.592-597, 2008.

A. Murtezani, Z. Ibraimi, A. Bakalli, S. Krasniqi, E. D. Disha et al., « The effect of aerobic exercise on quality of life among breast cancer survivors: a randomized controlled trial, J. Cancer Res. Ther, vol.10, pp.658-664, 2014.

N. Mutrie, A. M. Campbell, F. Whyte, A. Mcconnachie, C. Emslie et al., « Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial, BMJ, vol.334, p.517, 2007.

N. S. Mutschler, C. Scholz, T. W. Friedl, T. Zwingers, P. A. Fasching et al., Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study, vol.18, pp.175-183, 2018.

J. Nedergaard, T. Bengtsson, and B. Cannon, « Unexpected evidence for active brown adipose tissue in adult humans, Am. J. Physiol. Endocrinol. Metab, vol.293, pp.444-452, 2007.

M. L. Neuhouser, A. K. Aragaki, R. L. Prentice, J. E. Manson, R. Chlebowski et al., Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials, JAMA Oncol, vol.1, pp.611-621, 2015.

H. B. Nichols, A. Trentham-dietz, K. M. Egan, L. Titus-ernstoff, M. D. Holmes et al., Body mass index before and after breast cancer diagnosis: associations with all-cause, breast cancer, and cardiovascular disease mortality, Cancer Epidemiol. Biomark. Prev. Publ. Am. Assoc. Cancer Res. Cosponsored Am. Soc. Prev. Oncol, vol.18, pp.1403-1409, 2009.

H. Nilsson, U. Angerås, D. Bock, M. Börjesson, A. Onerup et al., « Is preoperative physical activity related to post-surgery recovery? A cohort study of patients with breast cancer, BMJ Open, vol.6, p.7997, 2016.

M. J. Nissen, A. Shapiro, and K. K. Swenson, Changes in weight and body composition in women receiving chemotherapy for breast cancer, Clin. Breast Cancer, vol.11, pp.52-60, 2011.

K. J. Nkhata, A. Ray, T. F. Schuster, M. E. Grossmann, and M. P. Cleary, Effects of adiponectin and leptin co-treatment on human breast cancer cell growth, Oncol. Rep. juin, vol.21, pp.1611-1619, 2009.

M. Noble, C. Russell, L. Kraemer, and M. Sharratt, « UW WELL-FIT: the impact of supervised exercise programs on physical capacity and quality of life in individuals receiving treatment for cancer

, Support. Care Cancer Off. J. Multinatl. Assoc. Support. Care Cancer, vol.20, pp.865-873, 2012.

S. J. Nomura, C. Dash, L. Rosenberg, J. Palmer, and L. L. Adams-campbell, Sedentary time and breast cancer incidence in African American women ». Cancer Causes Control CCC, vol.27, pp.1239-1252, 2016.

K. A. Nyrop, L. F. Callahan, R. J. Cleveland, L. L. Arbeeva, B. S. Hackney et al., Randomized Controlled Trial of a Home-Based Walking Program to Reduce Moderate to Severe Aromatase Inhibitor-Associated Arthralgia in Breast Cancer Survivors ». The Oncologist, vol.22, pp.1238-1249, 2017.

K. A. Nyrop, A. M. Deal, J. T. Lee, H. B. Muss, S. K. Choi et al., Weight changes in postmenopausal breast cancer survivors over 2 years of endocrine therapy: a retrospective chart review, Breast Cancer Res. Treat, 2017.

K. A. Nyrop, A. M. Deal, J. T. Lee, H. B. Muss, S. K. Choi et al., Weight gain in hormone receptor-positive (HR+) early-stage breast cancer: is it menopausal status or something else?, Breast Cancer Res. Treat, 2017.

K. A. Nyrop, H. B. Muss, B. Hackney, R. Cleveland, M. Altpeter et al., Feasibility and promise of a 6-week program to encourage physical activity and reduce joint symptoms among elderly breast cancer survivors on aromatase inhibitor therapy, J. Geriatr. Oncol, vol.5, pp.148-155, 2014.

K. A. Nyrop, G. R. Williams, H. B. Muss, and S. S. Shachar, Weight gain during adjuvant endocrine treatment for early-stage breast cancer: What is the evidence?, Breast Cancer Res. Treat, vol.158, pp.203-217, 2016.

S. Ohsumi, K. Shimozuma, Y. Ohashi, A. Takeuchi, K. Suemasu et al., Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02, Oncology, vol.82, pp.131-138, 2012.

2. «. Oms and . Oms-|-obésité, prévention et prise en charge de l'épidémie mondiale, OMS [En ligne, 2018.

J. Orava, P. Nuutila, M. E. Lidell, V. Oikonen, T. Noponen et al., « Different metabolic responses of human brown adipose tissue to activation by cold and insulin, Cell Metab, vol.14, pp.272-279, 2011.

C. C. Orgéas, P. Hall, L. U. Rosenberg, and K. Czene, « The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer, Breast Cancer Res. BCR, vol.10, p.107, 2008.

J. Park, T. S. Morley, M. Kim, D. J. Clegg, and P. E. Scherer, Obesity and cancer-mechanisms underlying tumour progression and recurrence, Nat. Rev. Endocrinol, vol.10, pp.455-465, 2014.

R. Patterson, E. Mcnamara, M. Tainio, T. H. De-sá, A. D. Smith et al., « Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis », Eur. J. Epidemiol, vol.33, pp.811-829, 2018.

D. Paulo, T. R. Winters-stone, K. M. Viezel, J. Rossi, F. E. Simões et al., Effects of resistance plus aerobic training on body composition and metabolic markers in older breast cancer survivors undergoing aromatase inhibitor therapy, Exp. Gerontol, vol.111, pp.210-217, 2018.

B. Pedersen, C. Delmar, T. Lörincz, U. Falkmer, and M. Grønkjaer, « Investigating Changes in Weight and Body Composition Among Women in Adjuvant Treatment for Breast Cancer: A Scoping Review ». Cancer Nurs, 2018.

C. N. Perera, H. G. Chin, N. Duru, and I. G. Camarillo, « Leptin-regulated gene expression in MCF-7 breast cancer cells: mechanistic insights into leptin-regulated mammary tumor growth and progression, J. Endocrinol, vol.199, pp.221-233, 2008.

A. Pfeifer, L. S. Hoffmann, and . Brown, beige, and white: the new color code of fat and its pharmacological implications, Annu. Rev. Pharmacol. Toxicol, vol.55, pp.207-227, 2015.

P. D. Pharoah, N. E. Day, S. Duffy, D. F. Easton, and B. Ponder, A. « Family history and the risk of breast cancer: a systematic review and meta-analysis », Int. J. Cancer, vol.29, issue.1997, pp.800-809
URL : https://hal.archives-ouvertes.fr/hal-01261770

B. M. Pinto, G. M. Frierson, C. Rabin, J. J. Trunzo, and B. H. Marcus, « Home-based physical activity intervention for breast cancer patients, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.20, issue.2005, pp.3577-3587

D. F. Pisani, V. Barquissau, J. Chambard, D. Beuzelin, R. A. Ghandour et al., Mitochondrial fission is associated with UCP1 activity in human brite/beige adipocytes ». Mol. Metab, vol.7, pp.35-44, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02111789

M. C. Playdon, M. B. Bracken, T. B. Sanft, J. A. Ligibel, M. Harrigan et al., Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis, J. Natl. Cancer Inst, vol.107, p.275

. Pnns, Programme national nutrition-santé, p.66, 2011.

M. N. Pollak, E. S. Schernhammer, and S. E. Hankinson, Insulin-like growth factors and neoplasia, Nat. Rev. Cancer, vol.4, pp.505-518, 2004.

A. R. Proença, R. A. Sertié, A. C. Oliveira, A. B. Campaña, R. O. Caminhotto et al., « New concepts in white adipose tissue physiology ». Braz, J. Med. Biol. Res. Rev. Bras. Pesqui. Medicas E Biol. février, vol.47, pp.192-205, 2014.

C. Rabin, B. Pinto, S. Dunsiger, J. Nash, and P. Trask, « Exercise and relaxation intervention for breast cancer survivors: feasibility, acceptability and effects, vol.18, pp.258-266, 2009.

M. J. Reed, N. G. Coldham, S. R. Patel, M. W. Ghilchik, and V. H. James, Interleukin-1 and interleukin-6 in breast cyst fluid: their role in regulating aromatase activity in breast cancer cells, J. Endocrinol. mars, vol.132, pp.5-8, 1992.

B. N. Reeves, S. R. Dakhil, J. A. Sloan, S. L. Wolf, K. N. Burger et al., Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1

G. K. Reeves, K. Pirie, V. Beral, J. Green, E. Spencer et al., Million Women Study Collaboration. « Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study, BMJ, vol.335, p.1134, 2007.

M. Reeves, E. Winkler, N. Mccarthy, S. Lawler, C. Terranova et al., « The Living Well after Breast Cancer TM Pilot Trial: a weight loss intervention for women following treatment for breast cancer, Asia Pac. J. Clin. Oncol, vol.13, pp.125-136, 2017.

R. Gonzalez, R. Watters, A. Xu, Y. Singh, U. P. Mann et al., Leptinsignaling inhibition results in efficient anti-tumor activity in estrogen receptor positive or negative breast cancer, Breast Cancer Res. BCR, vol.11, p.36, 2009.

A. G. Renehan, M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen, « Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies, Lancet Lond. Engl, vol.16, pp.569-578, 2008.

K. Rhiem, C. Engel, M. Graeser, S. Zachariae, K. Kast et al., The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study, Breast Cancer Res. BCR, vol.14, p.156

D. Richard and F. Picard, Brown fat biology and thermogenesis, vol.16, pp.1233-1260, 2011.

J. Robidoux, T. L. Martin, and S. Collins, « Beta-adrenergic receptors and regulation of energy expenditure: a family affair, Annu. Rev. Pharmacol. Toxicol, vol.44, pp.297-323, 2004.

C. L. Rock, C. Doyle, W. Demark-wahnefried, J. Meyerhardt, K. S. Courneya et al., « Nutrition and physical activity guidelines for cancer survivors, CA. Cancer J. Clin, vol.62, pp.243-274, 2012.

C. L. Rock, S. W. Flatt, V. Newman, B. J. Caan, M. N. Haan et al., « Factors associated with weight gain in women after diagnosis of breast cancer. Women's Healthy Eating and Living Study Group, J. Am. Diet. Assoc. octobre, vol.99, pp.1212-1221, 1999.

D. P. Rose, D. Komninou, and G. Stephenson, « Obesity, adipocytokines, and insulin resistance in breast cancer, Obes. Rev, vol.5, pp.153-165, 2004.

R. Robert, B. Steven, N. , A. Ross, C. Timothy et al., Wisløff Ulrik. « Importance of Assessing Cardiorespiratory Fitness in Clinical Practice: A Case for Fitness as a Clinical Vital Sign: A Scientific Statement From the American Heart Association, vol.134, pp.653-699, 2016.

J. Rouëssé and H. Sancho-garnier, Members de la commission III (Cancérologie). « [Organized breast cancer screening, Bull. Acad. Natl. Med. février, vol.198, pp.369-386, 2014.

J. R. Ruiz, B. Martinez-tellez, G. Sanchez-delgado, C. M. Aguilera, and A. Gil, « Regulation of energy balance by brown adipose tissue: at least three potential roles for physical activity, Br. J. Sports Med, vol.49, pp.972-973, 2015.

M. Saito, Y. Okamatsu-ogura, M. Matsushita, K. Watanabe, T. Yoneshiro et al., « High incidence of metabolically active brown adipose tissue in healthy adult humans: effects of cold exposure and adiposity, vol.58, pp.1526-1531, 2009.

G. Sanchez-delgado, B. Martinez-tellez, J. Olza, C. M. Aguilera, G. Angel et al., Role of Exercise in the Activation of Brown Adipose Tissue, Ann. Nutr. Metab, vol.25, issue.2015, pp.21-32

G. Sanchez-delgado, B. Martinez-tellez, J. Olza, C. M. Aguilera, I. Labayen et al., « Activating brown adipose tissue through exercise (ACTIBATE) in young adults: Rationale, design and methodology », Contemp. Clin. Trials, vol.45, pp.416-425, 2015.

N. Saquib, S. W. Flatt, L. Natarajan, C. A. Thomson, W. A. Bardwell et al., Weight gain and recovery of pre-cancer weight after breast cancer treatments: evidence from the women's healthy eating and living (WHEL) study », Breast Cancer Res. Treat, vol.105, pp.177-186, 2007.

D. B. Sawyer, Anthracyclines and heart failure, 21 mars 2013, vol.368, pp.1154-1156

N. K. Saxena, L. Taliaferro-smith, B. B. Knight, D. Merlin, F. A. Anania et al., « Bidirectional crosstalk between leptin and insulin-like growth factor-I signaling promotes invasion and migration of breast cancer cells via transactivation of epidermal growth factor receptor, Cancer Res, vol.68, pp.9712-9722, 2008.

D. Schmid and M. F. Leitzmann, Association between physical activity and mortality among breast cancer and colorectal cancer survivors: a systematic review and meta-analysis, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.25, pp.1293-1311, 2014.

S. Daniela and M. F. Leitzmann, Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis, J. Natl. Cancer Inst, vol.106, 2014.

K. H. Schmitz, M. L. Neuhouser, T. Agurs-collins, K. A. Zanetti, L. Cadmus-bertram et al., Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity, J. Natl. Cancer Inst, vol.105, pp.1344-1354

A. Schönherr, V. Aivazova-fuchs, K. Annecke, J. Jückstock, P. Hepp et al., « Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer ». Breast Care Basel Switz, vol.7, pp.289-295, 2012.

G. Schvartsman, A. M. Gutierrez-barrera, J. Song, N. T. Ueno, S. K. Peterson et al., « Association between weight gain during adjuvant chemotherapy for early-stage breast cancer and survival outcomes ». Cancer Med, 2017.

A. L. Schwartz, « Exercise and weight gain in breast cancer patients receiving chemotherapy, vol.8, pp.231-237, 2000.

A. L. Schwartz, K. Winters-stone, and B. Gallucci, « Exercise effects on bone mineral density in women with breast cancer receiving adjuvant chemotherapy, Oncol. Nurs. Forum, vol.34, pp.627-633, 2007.

R. Segal, W. Evans, D. Johnson, J. Smith, S. Colletta et al., « Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.19, pp.657-665, 2001.

A. Seidman, C. Hudis, M. K. Pierri, S. Shak, V. Paton et al., « Cardiac dysfunction in the trastuzumab clinical trials experience, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 1 mars, vol.20, pp.1215-1221, 2002.

E. Senkus, S. Kyriakides, S. Ohno, F. Penault-llorca, P. Poortmans et al., ESMO Guidelines Committee. « Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol. Off. J. Eur. Soc. Med. Oncol, vol.26, issue.5, pp.8-30, 2015.

I. Sestak, W. Distler, J. F. Forbes, M. Dowsett, A. Howell et al., « Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial, 20 juillet 2010, vol.28, pp.3411-3415

I. Sestak, M. Harvie, A. Howell, J. F. Forbes, M. Dowsett et al., « Weight change associated with anastrozole and tamoxifen treatment in postmenopausal women with or at high risk of developing breast cancer, Breast Cancer Res. Treat, vol.134, pp.727-734

I. G. Shabalina, N. Petrovic, D. Jong, J. M. Kalinovich, A. V. Cannon et al., UCP1 in brite/beige adipose tissue mitochondria is functionally thermogenic ». Cell Rep, vol.12, pp.1196-1203

R. Simões, L. M. Silva, A. L. Cruz, V. G. Fraga, A. De-paula-sabino et al., « Troponin as a cardiotoxicity marker in breast cancer patients receiving anthracycline-based chemotherapy: A narrative review, Biomed. Pharmacother. Biomedecine Pharmacother, vol.107, pp.989-996, 2018.

T. Sim?nek, M. Stérba, O. Popelová, M. Adamcová, R. Hrdina et al., Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron, Pharmacol. Rep. PR. février, vol.61, pp.154-171, 2009.

T. Skurk, C. Alberti-huber, C. Herder, and H. Hauner, « Relationship between adipocyte size and adipokine expression and secretion, J. Clin. Endocrinol. Metab, vol.92, pp.1023-1033, 2007.

D. Slamon, W. Eiermann, N. Robert, T. Pienkowski, M. Martin et al., Breast Cancer International Research Group. « Adjuvant trastuzumab in HER2-positive breast cancer, N. Engl. J. Med, vol.365, pp.1273-1283, 2011.

D. J. Slamon, G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich et al., Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene, Science. 9 janvier 1987, vol.235, pp.177-182

I. Smith, D. Yardley, H. Burris, D. Boer, R. Amadori et al., Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE)

». Trial, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.35, pp.1041-1048

J. C. Sorensen, B. D. Cheregi, C. A. Timpani, K. Nurgali, A. Hayes et al., Inadvertent targets in chemotherapy-induced skeletal muscle toxicity and wasting?, Cancer Chemother. Pharmacol, vol.78, pp.673-683, 2016.

R. M. Speck, K. S. Courneya, L. C. Mâsse, S. Duval, and K. H. Schmitz, An update of controlled physical activity trials in cancer survivors: a systematic review and meta-analysis, J. Cancer Surviv. Res. Pract, vol.4, pp.87-100, 2010.

R. M. Speck, A. Demichele, J. T. Farrar, S. Hennessy, J. J. Mao et al., « Taste alteration in breast cancer patients treated with taxane chemotherapy: experience, effect, and coping strategies ». Support. Care Cancer, vol.21, pp.549-555

N. L. Spector, Y. Yarden, B. Smith, L. Lyass, P. Trusk et al., Activation of AMP-activated protein kinase by human EGF receptor 2/EGF receptor tyrosine kinase inhibitor protects cardiac cells, Proc. Natl. Acad. Sci. U. S. A, vol.104, pp.10607-10612, 2007.

H. Starobova and I. Vetter, « Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy, Front. Mol. Neurosci, vol.10, p.174, 2017.

S. Steinbach, T. Hummel, C. Böhner, S. Berktold, W. Hundt et al., « Qualitative and quantitative assessment of taste and smell changes in patients undergoing chemotherapy for breast cancer or gynecologic malignancies, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.27, pp.1899-1905, 2009.

K. Subbaramaiah, P. G. Morris, X. K. Zhou, M. Morrow, B. Du et al., Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women ». Cancer Discov, vol.2, pp.356-365, 2012.

L. Sun, Y. Zhu, Q. Qian, and L. Tang, « Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis, vol.97, p.11220, 2018.

A. K. Swisher, J. Abraham, D. Bonner, D. Gilleland, G. Hobbs et al., Vona-Davis L. « Exercise and dietary advice intervention for survivors of triple-negative breast cancer: effects on body fat, physical function, quality of life, and adipokine profile ». Support. Care Cancer Off, J. Multinatl. Assoc. Support. Care Cancer, vol.23, pp.2995-3003, 2015.

T. K. Tay, A. A. Thike, N. Pathmanathan, A. R. Jara-lazaro, J. Iqbal et al., Using computer assisted image analysis to determine the optimal Ki67 threshold for predicting outcome of invasive breast cancer, Oncotarget, vol.9, pp.11619-11630, 2018.

E. Thivat, S. Thérondel, O. Lapirot, C. Abrial, P. Gimbergues et al., « Weight change during chemotherapy changes the prognosis in non metastatic breast cancer for the worse, BMC Cancer, vol.10, p.648

C. Tran, K. Gariani, and P. J. , Insulin and cancer: myth or reality?, ». Rev. Med. Suisse. 9 juin 2010, vol.6, pp.1188-1190, 1192.

N. Travier, A. Fonseca-nunes, C. Javierre, E. Guillamo, L. Arribas et al., « Effect of a diet and physical activity intervention on body weight and nutritional patterns in overweight and obese breast cancer survivors, Med. Oncol. Northwood Lond. Engl, vol.31, p.783, 2014.

O. Trédan, A. Bajard, A. Meunier, P. Roux, I. Fiorletta et al., « Body weight change in women receiving adjuvant chemotherapy for breast cancer: a French prospective study, Clin. Nutr. Edinb. Scotl, vol.29, pp.187-191, 2010.

M. S. Tremblay, R. C. Colley, T. J. Saunders, G. N. Healy, and N. Owen, « Physiological and health implications of a sedentary lifestyle, Appl. Physiol. Nutr. Metab. Physiol. Appliquée Nutr. Métabolisme, vol.35, pp.725-740

R. R. Turner, L. Steed, H. Quirk, R. U. Greasley, J. M. Saxton et al., « Interventions for promoting habitual exercise in people living with and beyond cancer, Cochrane Database Syst. Rev, vol.9, p.10192, 2018.

J. K. Vallance, K. S. Courneya, R. C. Plotnikoff, Y. Yasui, and J. R. Mackey, Randomized controlled trial of the effects of print materials and step pedometers on physical activity and quality of life in breast cancer survivors, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol, vol.25, pp.2352-2359, 2007.

M. E. Vázquez-vela, N. Torres, and A. R. Tovar, « White adipose tissue as endocrine organ and its role in obesity, Arch. Med. Res, vol.39, pp.715-728, 2008.

K. A. Virtanen, M. E. Lidell, J. Orava, M. Heglind, R. Westergren et al., « Functional brown adipose tissue in healthy adults, N. Engl. J. Med, vol.9, pp.1518-1525, 2009.

L. Vona-davis, M. Howard-mcnatt, D. P. Rose, and . Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer, Obes. Rev. Off. J. Int. Assoc. Study Obes, vol.8, pp.395-408, 2007.

D. Vries, Y. C. Van-den-berg, M. M. De-vries, J. H. Boesveldt, S. De-kruif et al., « Differences in dietary intake during chemotherapy in breast cancer patients compared to women without cancer, vol.25, pp.2581-2591, 2017.

R. A. Walker, E. Lees, M. B. Webb, and S. J. Dearing, Breast carcinomas occurring in young women (< 35 years) are different », Br. J. Cancer. décembre, vol.74, pp.1796-1800, 1996.

K. B. Wallace, Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis, Cardiovasc. Toxicol, vol.7, pp.101-107, 2007.

K. B. Wallace, E. Hausner, E. Herman, G. D. Holt, J. T. Macgregor et al., Serum troponins as biomarkers of drug-induced cardiac toxicity, Toxicol. Pathol, vol.32, pp.106-121, 2004.

J. Wang, H. Cai, . Wang-c.-y, J. Zhang, and . Zhang-m, Body weight changes in breast cancer patients following adjuvant chemotherapy and contributing factors, vol.2, pp.105-110, 2014.

. Wcrf/aicr and . Diet, Physical Activity and Cancer: a Global Perspective The Third Expert Report, World Cancer Res, 2018.

C. Wendt and S. Margolin, Identifying breast cancer susceptibility genes -a review of the genetic background in familial breast cancer, Acta Oncol, vol.0, pp.1-12, 2019.

, Geneva : World Health Organization, WHO. Global Recommendations on Physical Activity for Health, 2010.

D. Sur, , pp.978-92

E. G. Wilmot, C. L. Edwardson, F. A. Achana, M. J. Davies, T. Gorely et al., « Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis », Diabetologia, vol.55, pp.2895-2905, 2012.

J. Wu, P. Boström, L. M. Sparks, L. Ye, J. H. Choi et al., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human, Cell, vol.150, pp.366-376

H. W. Yeung, R. K. Grewal, M. Gonen, H. Schöder, and S. M. Larson, « Patterns of (18)F-FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET, J. Nucl. Med. Off. Publ. Soc. Nucl. Med. novembre, vol.44, pp.1789-1796, 2003.

T. Yoneshiro, S. Aita, M. Matsushita, T. Kameya, K. Nakada et al., « Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men, vol.19, pp.13-16, 2011.

Y. Zeng, M. Huang, A. S. Cheng, Y. Zhou, and W. K. So, Meta-analysis of the effects of exercise intervention on quality of life in breast cancer survivors ». Breast Cancer Tokyo Jpn, vol.21, pp.262-274, 2014.

S. Zhang, X. Liu, T. Bawa-khalfe, L. Lu, Y. L. Lyu et al., Identification of the molecular basis of doxorubicin-induced cardiotoxicity, Nat. Med, vol.18, pp.1639-1642, 2012.

Y. Y. Zhao, D. R. Sawyer, R. R. Baliga, D. J. Opel, X. Han et al., « Neuregulins promote survival and growth of cardiac myocytes. Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricular myocytes, J. Biol. Chem. 24 avril, vol.273, pp.10261-10269, 1998.

Q. Zheng, S. M. Dunlap, J. Zhu, E. Downs-kelly, J. Rich et al., Reizes O. « Leptin deficiency suppresses MMTV-Wnt-1 mammary tumor growth in obese mice and abrogates tumor initiating cell survival, Endocr. Relat. Cancer, vol.18, pp.491-503, 2011.

W. Zhou, S. Guo, and R. R. Gonzalez-perez, Leptin pro-angiogenic signature in breast cancer is linked to IL-1 signalling, Br. J. Cancer, vol.104, pp.128-137, 2011.

W. Zhu, D. Li, X. Li, J. Ren, W. Chen et al., Association between adjuvant docetaxel-based chemotherapy and breast cancer-related lymphedema, Anticancer. Drugs, vol.28, pp.350-355, 2017.

M. C. Zingaretti, F. Crosta, A. Vitali, M. Guerrieri, A. Frontini et al., « The presence of UCP1 demonstrates that metabolically active adipose tissue in the neck of adult humans truly represents brown adipose tissue, FASEB J. Off. Publ. Fed. Am. Soc. Exp. Biol, vol.23, pp.3113-3120, 2009.